Clinical Trial Update: Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating methods to attenuate ischemia-reperfusion injury in living donor kidney transplantation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury
• Kidney Transplantation
• Renal Transplantation

Snippet

Sponsor: Georgetown University | Conditions: Kidney Transplantation, Renal Transplantation | Phase 4 | Status: WITHDRAWN